 | « Back to article | Print this article |
The rise in profits was boosted by a good demand for its products in the regulated markets of Europe and the United States. The outbreak of swine flu, in particular, generated a huge demand for Opto's products. The company got good orders for its thermometers in most of the markets across the world, including the domestic market.
"The company currently has an order book of five months for this product due to the swine flu impact," Vinod Ramnani, chairman & managing director, OCI, told Business Standard.
The company's total income for the period rose by 76.8 per cent to Rs 213.11 crore, compared with the same period a year ago. Its operational profits for the quarter more than doubled to Rs 65.98 crore, compared with Rs 31.08 crore earlier.
For the year ended March 31, 2009, the company reported a rise of 60.3 per cent to Rs 209.4 crore, as compared with the previous year. Its total income for the year rose by 74.8 per cent to Rs 818.5 crore. Operational profit for the full year went up by 87.4 per cent to Rs 245.3 crore.
On a consolidated basis, 23 per cent of the turnover is from the invasive segment, 75 per cent from the non-invasive segment and 2 per cent from other businesses. The company has two main business sections consisting of healthcare and information technology.
"New products to be launched from Criticare and Eurocor in the coming year are expected to give us a technology lead in the industry. We also hope to access new geographies for both the segments over the current year," Ramnani said.
The earnings per share for the year went up to Rs 12.97 from Rs 8.09 a year ago. The board of directors has recommended a dividend payment of Rs 4 per share on equity shares of Rs 10 each, subject to shareholders' approval.
